Age, sex and practice variations in the use of statins in general practice in England and Wales

被引:44
作者
Majeed, A
Moser, K
Maxwell, R
机构
[1] Off Natl Stat, London SW1V 2QQ, England
[2] UCL, Sch Publ Policy, London WC1H 9EZ, England
来源
JOURNAL OF PUBLIC HEALTH MEDICINE | 2000年 / 22卷 / 03期
关键词
statins; prescribing; primary care; comparative study;
D O I
10.1093/pubmed/22.3.275
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Statins are highly effective in reducing the risk of sudden cardiac death and other acute coronary events in patients with pre-existing ischaemic heart disease or with raised blood cholesterol levels. However, relatively little is known about how statins are used in primary care. The objectives of this study were to investigate age, sex and inter-practice variations in the prescribing of statins. Methods This was an observational study of statin prescribing rates in 288 general practices in England and Wales that contributed data to the General Practice Research Database in 1996. Results In 1996, 0.7 per cent of men and 0.5 per cent of women received a prescription for a statin. In the subgroup of patients with a general practitioner (GP) diagnosis of ischaemic heart disease, 13.3 per cent of men and 8.2 per cent of women received a prescription for a statin in 1996. Below the age of 65 years, men with ischaemic heart disease were more likely to be prescribed a statin than were women. Patients aged 75 years and over with ischaemic heart disease were unlikely to be prescribed a statin irrespective of their sex. The percentage of patients prescribed statins in individual practices varied from 0.1 to 2.3 per cent in men and from 0 to 2.3 per cent in women. The recorded prevalence of ischaemic heart: disease explained only 12 per cent of this variation in men and 7 per cent in women. Conclusions There are large age, sex and inter-practice variations in the use of statins in primacy care, which are poorly explained by measures of health need. Developing and implementing clinical guidelines to accompany the introduction of new drugs for the management of common chronic disorders should be seen as a priority for GPs, primary care groups and the National Institute of Clinical Excellence.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 23 条
[1]  
Baxter C, 1998, BMJ-BRIT MED J, V317, P1134
[2]  
*DEP HLTH, 1998, PRESCR COST AN 1991
[3]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[4]   Indications for cholesterol-lowering medication: comparison of risk-assessment methods [J].
Durrington, PN ;
Prais, H ;
Bhatnagar, D ;
France, M ;
Crowley, V ;
Khan, J ;
Morgan, J .
LANCET, 1999, 353 (9149) :278-281
[5]  
Fairhurst K, 1998, BMJ-BRIT MED J, V317, P1130
[6]   Gambling with cardiovascular risk: picking the winners and the losers [J].
Grover, S .
LANCET, 1999, 353 (9149) :254-255
[7]   A simple computer program for guiding management of cardiovascular risk factors and prescribing [J].
Hingorani, AD ;
Vallance, P .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :101-105
[8]  
Hollowell J, 1997, Popul Trends, P36
[9]   What can PACT tell us about prescribing in general practice? [J].
Majeed, A ;
Evans, N ;
Head, P .
BRITISH MEDICAL JOURNAL, 1997, 315 (7121) :1515-1519
[10]   Unified budgets for primary care groups [J].
Majeed, A ;
Malcolm, L .
BRITISH MEDICAL JOURNAL, 1999, 318 (7186) :772-776